Rochester Skin Lymphoma Medical Group, PLLC

Quick facts

Phase 2 pipeline

• Valchlor 0.016 % Topical Gel

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Rochester Skin Lymphoma Medical Group, PLLC portfolio CI brief
• Rochester Skin Lymphoma Medical Group, PLLC pipeline updates RSS

Related

• Sector hub: All tracked pharma companies